Skip to main content
Caplight Logo









GaleAI

GaleAI

Private
United StatesHealthcare & Life Scienceshttps://galeai.co

Company Overview

GaleAI operates in Healthcare & Life Sciences and is based in the United States. It was founded in 2021.

GaleAI is a healthtech company that provides an AI-powered medical coding and billing platform for healthcare providers and hospitals.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Medical AI, EHR & EMR, NLP & Conversational AI, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

GaleAI Comparables

Compare GaleAI with similar companies based on industry and business-model similarity.

GaleAI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Maverick Medical AI
83%
CodaMetrix
82%
Fathom
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

GaleAI Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for GaleAI. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Tyler Gonzalez

Co-Founder And Chief Medical Officer

Founding Team

Grant Muller

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

GaleAI Investors

Notable investors and investment history

GaleAI investors
InvestorRounds
Axiom PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 779% MoM.

  • Mar 1, 2026

    Monthly visitors increased 508% MoM, from 36 to 219.

Book a demo to see all signals

For institutional investors. Book with your work email.

GaleAI Filings

Explore SEC and related filing metadata, where available.

GaleAI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about GaleAI's valuation, stock price, and market status.

Is GaleAI a public or private company?

GaleAI is a private company.

What is the current stock price of GaleAI?

GaleAI is a private company, so its shares have no public market price. Caplight tracks GaleAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is GaleAI worth (valuation)?

Valuation information for GaleAI is not publicly available.

Can I buy GaleAI stock?

GaleAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was GaleAI's last funding round?

Funding round information for GaleAI is not publicly available.

Who are the main investors in GaleAI?

Key investors in GaleAI include Axiom Partners.

Will GaleAI IPO soon?

No public IPO plans have been announced for GaleAI.

How can I track GaleAI secondary market activity?

Caplight tracks bids, offers, and trades in GaleAI's shares on secondary markets.

Firmographic Details

HeadquartersUnited States
Employee Range5
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?